Medical - Health Information and Search Services

Medical Ethics - Advertising

To view only the most recent articles for this topic, go to our Monthly Online Newsletters page

Need more info on this topic?
Try our search services:
Medical Library Search »
Internet Search »

Medical Ethics and Advertising

General Information

NEWS:

As Doctors Write Prescriptions, Drug Company Writes a Check

AstraZeneca digs in over advertising criticisms

Bias seen in U.S. drug study reporting

Crestor ads draw fire; FDA could act

Curbs on Outside Deals at NIH Urged

Diuretics Study Gets Federal Help; Ads To Promote Inexpensive Drugs As Best Weapon Against Hypertension

Doctor Faults Aggressive Painkiller Ads

Doctors and drug companies are locked in "vicious circle"

Doctors often prescribe more expensive drugs

Doctors who tout iffy "cures" will face critical eye of FTC

Drug company influence extends to nurses, pharmacists, and patient groups

Drug company targets US state health officials

Drug controversies prompt call for clinical trial registry

Drug makers deceive doctors

FDA asks drugmaker to discontinue ad

Foregone conclusions

German prosecutors probe again into bribes by drug companies

GlaxoSmithKline faces US lawsuit over concealment of trial results

GlaxoSmithKline staff told not to publicise ineffectiveness of its drug

Groups blast new cholesterol guidelines

Health studies increasingly funded by food companies

Italian doctors face criminal allegations over bribes

MPs launch inquiry into influence of drug industry

New Cochrane policy tightens limits on industry funding

New Zealand moves to ban direct advertising of drugs

National Institutes of Health criticised for not preventing conflicts of interest

NIH needs 'drastic changes'

Nutritionist's work questioned

Officials reject claims of drug industry's influence

Only 6% of drug advertising material is supported by evidence

Petition to the FDA to remove the cholesterol-lowering drug rosuvastatin (CRESTOR) from the market (HRG Publication #1693)

Scandals have eroded US public's confidence in drug industry

Scientific freedom of speech seen as winner in suit between drug firm and pharmacologist

Scottish doctors will have to register financial links to drug companies

Secret US report surfaces on antidepressants in children

Some patient studies show bias, could affect patient treatment: study

States ask drug firms to report gifts to individual physicians

Stronger sanctions needed against companies that suppress data

To your health, and drug firms' too

US junior doctors found to be ignorant of drug companies' tactics

Wyeth found guilty of paying to boost use of a specific medicine

ARTICLES:

Accepting what we can learn from advertising's mirror of desire

Advertising: boon or bother?

Adwatch - Augmentim

Celebrex might not live up to its hype

Cochrane Collaboration's stand versus industry funding

COX-2 Inhibitors: A CLASS Act or Just VIGORously Promoted

Direct to consumer advertising

Drug therapy for Alzheimer's disease

Excess in the pharmaceutical industry

Getting ethics into practice

Industry Testing of Toxic Pesticides on Human Subjects Concluded "No Effect," Despite the Evidence

IS PSYCHIATRY FOR SALE?

Killing me softly: myth in pharmaceutical advertising

Marketing of medicines in India

Medical Doctors Versus Spin Doctors: Sorting Through Conflicting Information

No Free Lunch (internet web site)

Postmarketing surveillance is neededSSRI treatment for under-18s

The medical profession and the pharmaceutical industry: when will we open our eyes?

The whole truth and nothing but the truth? The research that Philip Morris did not want you to see

Vioxx, the implosion of Merck, and aftershocks at the FDA

JOURNAL ARTICLES:

A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. (Acad Med)

Anti-aging quackery: human growth hormone and tricks of the trade--more dangerous than ever. (J Gerontol A Biol Sci Med Sci)

[Breast cancer: dangers of alleged certainties] (Sante Publique)

Crossing professional boundaries in medicine: the slippery slope to patient sexual exploitation. (Med J Aust)

Direct-to-Consumer Pharmaceutical Advertising (Arch Intern Med)

Drug company experts advised staff to withhold data about SSRI use in children (CMAJ)

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. (JAMA)

Ethical issues for cancer screenings Five countries-four types of cancer. (Prev Med)

Ethics in medical information and advertising (International Journal of Gynecology & Obstetrics)

Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know. (J La State Med Soc)

Industry guidelines, laws and regulations ignored: quality of drug advertising in medical journals. (Pharmacoepidemiol Drug Saf)

Medical students' exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. (Acad Med)

Pharmaceutical advertising in emergency departments. (Acad Emerg Med)

[Physicians and drug industry: attitudes and practice] (Tidsskr Nor Laegeforen)

Professionalism for medicine: opportunities and obligations. (Iowa Orthop J)

Scientific Integrity, Fidelity and Conflicts of Interest (Curr Opin Psychiatry)

The ethics of pharmaceutical industry relationships with medical students. (Med J Aust)

INTERNET SITES:

AMA- Principles of Medical Ethics, June 2001

Healthy Skepticism

Media Doctor

NIH-Bioethics Journals

Red Flags

go to the topGo to the top

© 2004-2010, InfoMedSearch, LLC. All rights reserved. | Site design: mqstudio